Real-world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{0323a05f10ca46609f6dfe295a4fb3d9,

title = "Real-world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes",

author = "Wilson, {Jo L.} and Jennifer Dantzer",

year = "2021",

month = dec,

day = "1",

doi = "10.1542/peds.2021-053843RRRR",

language = "English (US)",

volume = "148",

pages = "S64--S65",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

}

TY - JOUR

T1 - Real-world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes

AU - Wilson, Jo L.

AU - Dantzer, Jennifer

PY - 2021/12/1

Y1 - 2021/12/1

UR - http://www.scopus.com/inward/record.url?scp=85147659298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147659298&partnerID=8YFLogxK

U2 - 10.1542/peds.2021-053843RRRR

DO - 10.1542/peds.2021-053843RRRR

M3 - Comment/debate

AN - SCOPUS:85147659298

SN - 0031-4005

VL - 148

SP - S64-S65

JO - Pediatrics

JF - Pediatrics

ER -